Physician profile
Paula Bebej
NPI 1881771459
$902.98
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $50.75 · 2021: $184 · 2022: $131 · 2023: $295 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $243.09 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $128.70 | 2019-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $122.94 | 2020-2021 | |
| Cranial Technologies, INC | $89.67 | 2019-2024 | Doc Band |
| Kaleo, INC. | $88.64 | 2022-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $87.50 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $50.05 | 2019 | |
| Sobi, INC | $38.96 | 2022-2023 | |
| Glaxosmithkline, LLC. | $30.00 | 2021 | |
| Corium, LLC | $23.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Bebej listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.